The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Screening of FGFR patients for FGFR directed clinical trials in Network Genomic Medicine (NGM): Real-world data.
 
Heather Scharpenseel
Research Funding - Janssen (Inst)
 
Florian Malchers
No Relationships to Disclose
 
Inken Terjung
Stock and Other Ownership Interests - Bayer (I)
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst)
 
Axel Hillmer
Research Funding - Dracen (Inst)
 
Sabine Merkelbach-Bruse
Honoraria - BMSi; Janssen
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Merck; Molecular Health; MSD; Novartis; Roche; Targos GmbH
 
Andreas H. Scheel
No Relationships to Disclose
 
Janna Siemanowski
Honoraria - AstraZeneca; Biocartis; Merck; Targos
Consulting or Advisory Role - Medizinischer Dienst Krankenversicherung Nordrhein
 
Matthias Scheffler
No Relationships to Disclose
 
Richard Riedel
No Relationships to Disclose
 
Anna Eisert
No Relationships to Disclose
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Janssen Oncology; Merck KGaA; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Rieke Nila Fischer
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
Research Funding - Bristol-Myers Squibb (Inst)
 
Jan-Philip Weber
Consulting or Advisory Role - Lilly
 
Theresa Westphal
No Relationships to Disclose
 
Anna Kron
No Relationships to Disclose
 
Juliane Sueptitz
No Relationships to Disclose
 
Roman K. Thomas
No Relationships to Disclose
 
Reinhard Buettner
No Relationships to Disclose
 
Juergen Wolf
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma Europe; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo; Loxo/Lilly; MSD; Novartis; Pfizer; Roche; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo/Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen; Takeda
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Lucia Nogova
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Dracen (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Janssen; Novartis; Pfizer